Targeting MAPK4 may offer a new therapeutic opportunity for TNBC
MAPK4 seems to be involved in promoting triple-negative breast cancer growth and its resistance to certain therapies.
Read More
triple-negative breast cancer
Study of spliceosome-targeting cancer therapies reveals an overlooked role of mis-spliced RNAs themselves
Endogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.
Read More
An integrated approach to finding new treatments for breast cancer
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And
Read More
A potential new purpose for an old drug
When it comes to finding new drugs to treat breast cancer, some scientists are taking an approach that could expedite the discovery of new treatments.
Read More
Above and beyond: Breast cancer treatment for the whole person
Stephanie D. Miller knew breast cancer ran in her family, and with her dense breast tissue, she was religious about getting her annual mammogram. She
Read More
Researchers target what makes triple negative breast cancer grow
Scientists have been looking for receptors —molecules on cancer cells — that promote the growth of cancers. But the receptors driving some cancer types like
Read More
What is triple negative breast cancer?
Breast cancer is a complex disease affecting thousands of Americans every year. However, some types of breast cancer are more aggressive than others, including triple
Read More
From treating cancer patients to developing cancer therapies: My journey so far
There are some people in your life who make a lasting first impression. There are other people that you meet who end up changing your
Read More
Exploiting cancer’s Achilles’ heel
What drives innovation? For Dr. Trey Westbrook it’s a personal mission to find new treatments for invasive breast cancer. His work focuses on the genetic
Read More